[Pre-Aug 2018] IMSCAR
- Published
Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?
Hughes, D., Hughes, D. A. & Pirmohamed, M., 1 Nov 2003.Research output: Contribution to conference › Paper
- Published
Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?
Hughes, D., Hughes, D. A. & Pirmohamed, M., 1 Nov 2003, In: Value in Health. 6, 6, p. 749Research output: Contribution to journal › Article › peer-review
- Published
Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?
Hughes, D., Hughes, D. A. & Pirmohamed, M., 1 Sept 2003.Research output: Contribution to conference › Paper
- Published
Abolition of prescription charges in Wales: the impact on medicines use in those who used to pay
Hughes, D., Groves, S., Cohen, D., Alam, M. F., Dunstan, F. D., Routledge, P. A., Hughes, D. A. & Myles, S., 1 Dec 2010, In: International Journal of Pharmacy Practice. 18, 6, p. 332-340Research output: Contribution to journal › Article › peer-review
- Published
Abolition of prescription copayments in Wales: an observational study on dispensing rates.
Hughes, D., Cohen, D., Alam, M. F., Dunstan, F. D., Myles, S., Hughes, D. A. & Routledge, P. A., 1 Aug 2010, In: Value in Health. 13, 5, p. 675-680Research output: Contribution to journal › Article › peer-review
- Published
Access to timely care in Portugal as compared to other European countries
Woods, R. T., Pereira, M. G., Stephan, A., Verhey, F., de Vugt, M., Wolfs, C., Handels, R., Verbeek, H., Kerpershoek, L., Bieber, A., Meyer, G., Marques, M., Barrios, H., Balsinha, C., Woods, R., Wimo, A., Selbaeck, G., Irving, K. & Zannetti, O., 1 Dec 2015, In: International Psychogeriatrics. 27, 1, p. S35-S36Research output: Contribution to journal › Article › peer-review
- Published
Accounting for non-compliance in pharmacoeconomic evaluations.
Hughes, D., Hughes, D. A., Bagust, A., Haycox, A. & Walley, T., 1 Jan 2001, In: Pharmacoeconomics. 19, 12, p. 1185-1197Research output: Contribution to journal › Article › peer-review
- Published
Accurate and practical dosing of African populations using a height, weight and age model designed for lapdap
Hughes, D., Hughes, D. A. & Bagust, A., 1 Nov 2002.Research output: Contribution to conference › Paper
- Published
Activity Increase Despite Arthritis (AÏDA): design of a Phase II randomised controlled trial evaluating an active management booklet for hip and knee osteoarthritis [ISRCTN24554946]
Williams, N., Amoakwa, E., Burton, K., Hendry, M., Belcher, J., Lewis, R., Hood, K., Jones, J. G., Bennett, P., Edwards, R. T., Neal, R., Andrew, G. & Wilkinson, C., 4 Sept 2009, In: BMC Family Practice. 10, 62, p. 1-9 62.Research output: Contribution to journal › Article › peer-review
- Published
Activity Increase Despite Arthritis (AÏDA): phase II randomised controlled trial of an active management booklet for hip and knee osteoarthritis in primary care
Williams, N. H., Amoakwa, E., Belcher, J., Edwards, R. T., Hassani, H., Hendry, M., Burton, K., Lewis, R., Hood, K., Jones, J., Bennett, P., Linck, P. G., Neal, R. D. & Wilkinson, C. E., 1 Aug 2011, In: British Journal of General Practice. 61, 589, p. e452-e458Research output: Contribution to journal › Article › peer-review
- Published
Additional therapy for young children with spastic cerebral palsy: a randomised controlled trial.
Weindling, A. M., Cunningham, C. C., Glenn, S. M., Edwards, R. T. & Reeves, D. J., 1 May 2007, In: Health Technology Assessment. 11, 16, p. 90Research output: Contribution to journal › Article › peer-review
- Published
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
Bellis, M. A., Williams, R., Aspinall, R., Bellis, M., Camps-Walsh, G., Cramp, M., Dhawan, A., Ferguson, J., Forton, D., Foster, G., Gilmore, I., Hickman, M., Hudson, M., Kelly, D., Langford, A., Lombard, M., Longworth, L., Martin, N., Moriarty, K., Newsome, P., O'Grady, J. & Pryke, R., 27 Nov 2014, In: The Lancet. 384, 9958, p. 1953-1997Research output: Contribution to journal › Article › peer-review
- Published
Adherence and variability in warfarin dose requirements: assessment in a prospective cohort
Hughes, D., Jorgensen, A. L., Hughes, D. A., Hanson, A., van Eker, D., Toh, C. H., Pirmohamed, M. & Williamson, P. R., 1 Jan 2013, In: Pharmacogenomics. 14, 2, p. 151-163Research output: Contribution to journal › Article › peer-review
- Published
Adherence of patients to long-term medication: a cross-sectional study of antihypertensive regimens in Austria
Lotsch, F., Auer-Hackenberg, L., Groger, M., Rehman, K., Morrison, V. L., Holmes, E. A., Parveen, S., Plumpton, C. O., Clyne, W., de Geest, S., Dobbels, F., Vrijens, B., Kardas, P., Hughes, D. & Ramharter, M., May 2015, In: Wiener klinische Wochenschrift. 127, 9-10, p. 379-384Research output: Contribution to journal › Article › peer-review
- Published
Adherence with HAART: pharmacoeconomic considerations
Hughes, D. & Hughes, D. A., 1 Jun 2007.Research output: Contribution to conference › Paper
- Published
Adverse childhood experiences and associations with health-harming behaviours in young adults: surveys in eight eastern European countries
Bellis, M. A., Hughes, K., Leckenby, N., Jones, L., Baban, A., Karcheva, M., Povilaitis, R., Pudule, I., Qirjako, G., Ulukol, B. & Raleva, M. T., 19 Jun 2014, In: Bulletin of the World Health Organization. 92, p. 641-655BResearch output: Contribution to journal › Article › peer-review
- Published
Adverse childhood experiences: retrospective study to determine their impact on adult health behaviours and health outcomes in a UK population.
Bellis, M. A., Lowey, H., Leckenby, N., Hughes, K. & Harrison, D., 14 Apr 2013, In: Journal of Public Health. 36, 1, p. 81-91Research output: Contribution to journal › Article › peer-review
- Published
Adverse drug reactions in economic evaluations
Hughes, D. & Hughes, D. A., 1 Jul 2007.Research output: Contribution to conference › Paper
- Published
Adverse drug reactions in economic evaluations
Hughes, D. & Hughes, D. A., 1 Mar 2007.Research output: Contribution to conference › Paper
- Published
Adverse drug reactions in economic evaluations
Hughes, D. & Hughes, D. A., 1 Jan 2007, In: Value in Health. 10, 3, p. A109Research output: Contribution to journal › Article › peer-review
- Published
Adverse drug reactions: analysis by regulatory authorities and by economists
Hughes, D. & Hughes, D. A., 1 Apr 2007.Research output: Contribution to conference › Paper
- Published
Alcohol age of initiation and long-term impact: a cross sectional survey of adults in England
Morleo, M., Jones, L. & Bellis, M. A., 30 Oct 2014, In: Journal of Substance Use.Research output: Contribution to journal › Article › peer-review
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Abacavir 600mg/lamivudine 300mg (Kivexa) in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus infection in adults and adolescents from 12 years of age.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.Research output: Book/Report › Commissioned report
- Published
All Wales Medicines Strategy Group Final Appraisal Report - Ambrisentan (Volibris) for pulmonary arterial hypertension.
Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2009, 2009 ed. Unknown.Research output: Book/Report › Commissioned report